MAZE
Common StockMaze Therapeutics, Inc.
Healthcare
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$101.2M
Portfolio Weight
67.60%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$149.7M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
MAZE
Common StockMaze Therapeutics, Inc.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$101.2M
Portfolio Weight
67.60%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$48.5M
Portfolio Weight
32.40%